Loading...

JANX JANUX THERAPEUTICS INC Company Mergers 8-K Filing

JNX

JNX

JANUX THERAPEUTICS INC

(JANX)

2026 8-K

Management Change

Annual Meeting Results

Financial Results Released

Board Reorganization

Financial Results Announcement

Collaboration Agreement

Financial Results Report

Management Change

Financial Statements

Financial Statements

Financial Results

Public Offering

Clinical Data Update

Financial Results

Financial Results Announcement

Departure of Directors and ...

Financial Results Announcement

Financial Results Announcement

Public Offering

Suspension of Prospectus Su...

Capital Resources and Inter...

Earnings Reports

Financial Results Announcement

Equity Offerings

Results of Operations and F...

Resignation of CMO

Delisting Notice

Equity Offering

Financial Results Announcement

Departure of Directors

Financial Results Announcement

External Links:

On January 21, 2026, Janux Therapeutics, Inc. entered into a partnership with Bristol-Myers Squibb for the development of a new cancer treatment, receiving an upfront payment of $15 million and potential milestone payments of up to $785 million.

AI Assistant

JANUX THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.